Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ...

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund launched on June ...

Article ‘Count’ and ‘Share’ for Genome and Company based on listed parameters only. The articles listed below published by authors from Genome and Company, organized by journal and article, represent ...

WASHINGTON (CNN) -- Researchers have sequenced the genome of the bacteria that causes cholera, a potentially fatal intestinal infection common in developing countries. The scientific achievement, to ...

Breakthrough high-performance computing solution delivers 3x higher throughput, cost efficiency, and faster life-saving discoveries ...